MEDAMI 2026 Valencia

Session

Session 2: Situation of Nuclear Medicine in Low- and Medium-Income Countries

15 May 2026, 16:00

Valencia Terminal Hub

Conveners

Session 2: Situation of Nuclear Medicine in Low- and Medium-Income Countries

• John Olivier Prior

Session 2: Situation of Nuclear Medicine in Low- and Medium-Income Countries: Session 3:

• There are no conveners in this block

14. Bridging the Gap: The SFMN Francophonie Working Group’s Educational Initiative for Nuclear Medicine in LMICs

Renaud Guignard

15/05/2026, 16:00

In view of the restricted and sporadic availability of NM procedures, an important impediment to the effective implementation of nuclear medicine technologies (NMTs) in LMICs is the sustainability of human capital expertise. In order to address this issue, the Francophonie Working Group ("GT Francophonie") of the French Society of Nuclear Medicine (SFMN) has launched a robust continuous...

22. Assessment of Nuclear Medicine Infrastructure in the Democratic Republic of Congo: Report of a IAEA Expert Mission

Renaud Guignard

15/05/2026, 16:20

Background and Mission Purpose
In November 2020, amidst the specific challenges of the global SARS-CoV-2 pandemic , an IAEA Technical Cooperation Expert Mission was conducted to assess the nuclear medicine situation in the Democratic Republic of Congo (DRC). Mandated under project ZA16014, "Sustaining Nuclear Medicine Infrastructure for the Improvement of the Management of Communicable...

26. Development and implementation of nuclear medicine services at the university clinics of Kinshasa (2020–2025)

Renaud Guignard

15/05/2026, 16:40

Background and implementation (2019 – 2022)
Following a strategic partnership between the University Clinics of Kinshasa (CUK) and the International Atomic Energy Agency (IAEA), facilitated by the CGEA/CREN-K, a Mediso SPECT Anyscan dual-head gamma camera was acquired in 2019. Technical installation and initial acceptance testing were completed in 2020 with support from regional...

34. The current status and perspective of nuclear medicine in Burkina Faso in 2026: Challenges in technology deployment and sustainability.

Dr Renaud Guignard (Service de médecine nucléaire Montpellier)

15/05/2026, 17:00

Introduction:
In sub-Saharan Africa, the transition toward molecular imaging remains a significant public health challenge. The establishment of the first nuclear medicine (NM) department in Burkina Faso at the Yalgado Ouédraogo University Hospital (CHUYO) in January 2012 marked a strategic turning point. Following fourteen years of operation, this study aims to provide a longitudinal...

24. Bridging the Gap: Bringing Nuclear Oncology to the Heart of Central Africa A Cyclotron for Kinshasa — Opportunities and Challenges

Prof. Dr. Ken Kudura

15/05/2026, 17:20

The Democratic Republic of Congo (DRC), with a population exceeding 102 million, currently operates with fewer than five nuclear medicine physicians, no PET/CT scanner, and no radiopharmaceutical production facility. Against a backdrop of more than 50,000 new cancer cases diagnosed annually and a single private radiotherapy unit serving the entire country, the gap between oncological need and...

6. Ten years of experience in developing medical imaging solutions for low-resource settings

Mr Merence Sibomana (MDS-Imaging srl)

15/05/2026, 17:40

We report ten years of experience in developing sustainable medical imaging solutions for low-resource settings, from the development of a CBCT prototype in 2016 to the implementation of radiology service digitalization in three sub-Saharan African countries.
The CBCT project, ImagXEco, was funded by the University of Louvain-la-Neuve and the Walloon Region with the aim of developing a...

18. Dynamic Status of Nuclear Medicine in Africa

Salah Eddine Bouyoucef (Emeritus Professor Nuclear Medicine Faculty of Medicine/University Hospital Bab El Oued Algiers Algeria)

15/05/2026, 18:00

Nuclear medicine and molecular imaging (NMMI) has experienced remarkable global growth over the past 50 years and now plays a crucial role in the development and implementation of strategies for managing major public health challenges in many countries. During this period, significant advances in technology, computing software, radiopharmacy, and instrumentation have enhanced the impact of...

8. Expanding Access to Precision Oncology in LMICs: Development of 99mTc-PSMA-HBED-CC for SPECT/CT Imaging

Shuichi Shiratori (Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand)

16/05/2026, 08:30

Prostate cancer represents a growing public health challenge in many low- and middle -income countries (LMICs). The global burden of prostate cancer continues to increase due to aging populations, improved detection, and lifestyle changes. However, healthcare systems in LMICs often face substantial constraints, including limited diagnostic infrastructure, unequal access to specialized oncology...

5. Starting off Theranostics in small hospitals in developing countries

Bob Omondi

16/05/2026, 08:50

Research Objective
To investigate how to begin targeted molecular therapies in less resourceful hospitals in developing countries
Introduction
Theranostics refers to use of the same radiopharmaceuticals for diagnostics and targeted molecular therapy (Konrad et al., 2021). It is a new treatment modality that promises personalized radiation therapy for cancer patients. It has been in practice...

7. Establishment of Local Production of 18F-Florbetapir for Cost-Effective Amyloid PET Imaging of Alzheimer’s Disease at Siriraj Hospital, Thailand

Tossaporn Siriprapa

16/05/2026, 09:10

Background: Alzheimer’s disease (AD) is the leading cause of dementia worldwide and poses an escalating public health burden, particularly in aging populations. Accurate early diagnosis is essential for optimal patient management and the implementation of emerging disease-modifying therapies. Positron emission tomography (PET) imaging with 18F-Florbetapir enables noninvasive in vivo...